We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,885
Increased
5,794
Reduced
5,768
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$622M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$597M
3
CMCSA icon
Comcast
CMCSA
+$461M
4
UNH icon
UnitedHealth
UNH
+$409M
5
MXIM
Maxim Integrated Products
MXIM
+$343M

Sector Composition

Rank Sector Weight
1 Technology 3.08%
2 Consumer Discretionary 2.25%
3 Financials 2.23%
4 Healthcare 2.22%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CYXT
12026
PUT
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$180K ﹤0.01%
+19,500
New +$182K
FTPAW
12027
DELISTED
FTAC Parnassus Acquisition Corp. Warrant
FTPAW
$180K ﹤0.01%
187,500
-264
-0.1% -$302
GNACW
12028
DELISTED
Group Nine Acquisition Corp. Warrant
GNACW
$180K ﹤0.01%
220,075
+86,742
+65% +$78.1K
AQN icon
12029
CALL
Algonquin Power & Utilities
AQN
$4.53B
$179K ﹤0.01%
12,200
-9,100
-43% -$140K
ENVB icon
12030
Enveric Biosciences
ENVB
$6.16M
$179K ﹤0.01%
10
+9
+900% +$175K
GLAD icon
12031
CALL
Gladstone Capital
GLAD
$446M
$179K ﹤0.01%
7,900
-500
-6% -$11.5K
LGMK
12032
DELISTED
LogicMark
LGMK
$179K ﹤0.01%
+86
New +$292K
LX
12033
CALL
LexinFintech Holdings
LX
$224M
$179K ﹤0.01%
30,400
-52,000
-63% -$401K
NGL icon
12034
CALL
NGL Energy Partners
NGL
$2.24B
$179K ﹤0.01%
75,600
+13,900
+23% +$27.1K
VRN
12035
PUT
DELISTED
Veren
VRN
$179K ﹤0.01%
38,800
+8,100
+26% +$29.9K
AFIB
12036
PUT
DELISTED
Acutus Medical Inc
AFIB
$179K ﹤0.01%
20,200
+9,600
+91% +$126K
AXDX
12037
PUT
DELISTED
Accelerate Diagnostics
AXDX
$178K ﹤0.01%
3,060
+710
+30% +$46.3K
CRMD icon
12038
CALL
CorMedix
CRMD
$588M
$178K ﹤0.01%
38,300
-44,300
-54% -$258K
CXAIW icon
12039
CXApp Inc Warrant
CXAIW
$765K
$178K ﹤0.01%
273,122
+183,397
+204% +$131K
EGY icon
12040
PUT
Vaalco Energy
EGY
$608M
$178K ﹤0.01%
60,500
+7,000
+13% +$18.5K
WATT icon
12041
PUT
Energous
WATT
$86M
$178K ﹤0.01%
142
-106
-43% -$152K
BIOC
12042
CALL
DELISTED
Biocept, Inc.
BIOC
$178K ﹤0.01%
1,483
+910
+159% +$106K
ADMA icon
12043
ADMA Biologics
ADMA
$2.12B
$177K ﹤0.01%
156,388
+28,373
+22% +$39.7K
DMAC icon
12044
PUT
DiaMedica Therapeutics
DMAC
$360M
$177K ﹤0.01%
44,100
+20,100
+84% +$76.9K
GLBS icon
12045
PUT
Globus Maritime Ltd
GLBS
$78.6M
$177K ﹤0.01%
60,600
+14,600
+32% +$44.4K
KALA icon
12046
CALL
KALA BIO
KALA
$18.3M
$177K ﹤0.01%
27
-10
-27% -$86.3K
XXII
12047
22nd Century Group
XXII
$1.49M
– –
0
– –
AIOT
12048
PUT
PowerFleet Inc
AIOT
$417M
$177K ﹤0.01%
26,400
-24,100
-48% -$167K
AONCW
12049
DELISTED
American Oncology Network, Inc. Warrant
AONCW
$177K ﹤0.01%
256,890
– –
HIBS icon
12050
CALL
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$17.4M
$176K ﹤0.01%
+155
New +$183K
480 481
482
483 484

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2021 Portfolio in Review

As of Q3 2021, Ken Griffin held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ken Griffin deployed $38.1B of net new capital in Q3 2021, opening 1,885 new positions and adding to 5,794 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 3.2% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Ken Griffin's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Ken Griffin added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Ken Griffin's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Ken Griffin fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Ken Griffin's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Ken Griffin opened 1,885 new positions and closed 1,724 in Q3 2021.
  • Ken Griffin's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.